{
    "eid": "2-s2.0-85085762882",
    "title": "Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative",
    "cover-date": "2020-07-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Acellular",
        "Interchangeability",
        "Pertussis",
        "Vaccines",
        "Whole-cell"
    ],
    "authors": [
        "Amar J. Chitkara",
        "M\u00f3nica Pujadas Ferrer",
        "Kevin Forsyth",
        "Nicole Guiso",
        "Ulrich Heininger",
        "Daniela Flavia Hozbor",
        "Rudzani Muloiwa",
        "Tina Q. Tan",
        "Usa Thisyakorn",
        "C. H. Wirsing von K\u00f6nig"
    ],
    "citedby-count": 4,
    "ref-count": 34,
    "ref-list": [
        "Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells",
        "Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood",
        "Review of vaccination in pregnancy to prevent pertussis in early infancy",
        "Principles of vaccine interchangeability",
        "Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study",
        "The pink book: pertussis",
        "Pertussis and other Bordetella infections (Chapter 129)",
        "Adverse event following immunization (AEFI) surveillance in India, position paper of Indian Academy of Pediatrics, 2013",
        "Recurrence risk of a hypotonic hyporesponsive episode in two Australian specialist immunisation clinics",
        "Combination vaccines",
        "Challenges for the registration of vaccines in emerging countries: Differences in dossier requirements, application and evaluation processes",
        "Immune responses to pertussis vaccines and disease",
        "Pertussis vaccines",
        "Comparison of 13 acellular pertussis vaccines: overview and serologic response",
        "Strategies to decrease pertussis transmission to infants",
        "Surveillance of pertussis: methods and implementation",
        "What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories",
        "Impact of maternally derived pertussis antibody titers on infant whole-cell pertussis vaccine response in a low income setting",
        "Why the MRC randomized trials of whooping cough (pertussis) vaccines remain important more than half a century after they were done",
        "Waning protection after fifth dose of acellular pertussis vaccine in children",
        "Vaccine adverse events reporting system globally",
        "The effect of maternal pertussis immunization on infant vaccine responses to a booster pertussis-containing vaccine in Vietnam",
        "Epidemiolog\u00eda \u2014 Vacunas-Vigilancia de ESAVI",
        "A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySixTM) to licensed combination vaccines in healthy infants",
        "Comparative analysis of pharmacovigilance systems in five Asian countries",
        "Comparison of adverse events following immunisation with acellular and whole-cell pertussis vaccines: a systematic review",
        "Complex correlates of protection after vaccination",
        "Deaths reported after pentavalent vaccine compared with death reported after diphtheria-tetanus-pertussis vaccine: an exploratory analysis",
        "Does whole-cell pertussis vaccine protect black South African infants? Assessment of post-vaccination events and antibody responses to pertussis toxin, filamentous haemagglutinin and agglutinogens 2 and 3",
        "Number and order of whole cell pertussis vaccines in infancy and disease protection",
        "Module 4: pertussis, update 2017",
        "Pertussis vaccines: WHO position paper \u2014 August 2015",
        "Immunization standards: safety of Quinvaxem (DTwP-HepB-Hib) pentavalent vaccine",
        "Risk of recurrence of adverse events following immunization: a systematic review"
    ],
    "affiliation": [
        {
            "affiliation-city": "Montevideo",
            "@id": "60071612",
            "affilname": "Universidad de la Republica",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60071612",
            "affiliation-country": "Uruguay"
        },
        {
            "affiliation-city": "La Plata",
            "@id": "60032057",
            "affilname": "Universidad Nacional de La Plata",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032057",
            "affiliation-country": "Argentina"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Adelaide",
            "@id": "60020828",
            "affilname": "Flinders University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020828",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Chicago",
            "@id": "60013227",
            "affilname": "Northwestern University Feinberg School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60013227",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Basel",
            "@id": "60006655",
            "affilname": "Universit\u00e4ts-Kinderspital Beider Basel",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006655",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Paris",
            "@id": "60001772",
            "affilname": "Institut Pasteur, Paris",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001772",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Cape Town",
            "@id": "60000356",
            "affilname": "University of Cape Town",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000356",
            "affiliation-country": "South Africa"
        },
        {
            "affiliation-city": "New Delhi",
            "@id": "112303307",
            "affilname": "Max Super Speciality Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112303307",
            "affiliation-country": "India"
        }
    ],
    "funding": [
        "GSK Biologicals SA",
        "GSK Biologicals and Sano\ufb01 Pasteur",
        "Novartis Vaccines",
        "Pfizer",
        "GlaxoSmithKline",
        "Merck",
        "MSD",
        "Merck",
        "Sano\ufb01 Pasteur"
    ]
}